All News

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

"Asymptomatic coronavirus spread is rare." World Health Organization explains the miscommunication.

The Lancet and NEJM recently retracted 2 studies after questions arose regarding the validity of the data used as the basis of the studies.

Get a snapshot of the diabetes data most important to primary care from the National Diabetes Statistics Report, 2020.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.

THEMIS trial results showed a statistically significant reduction in risk of MACE with ticagrelor plus aspirin vs aspirin alone in patients with CAD at high risk of first heart attack or stroke.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

Experts in infectious disease rate a wide range of summer activities as low, medium, or high COVID-19 risk. When your patients ask, you'll be ready.

Early forecasts of COVID-19 burden on US hospitals based on data from China may have underestimated need at peak infection, a new study suggests.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

The novel AI tool can help frontline health care workers quickly distinguish between COVID-19 pneumonia and non-COVID-19 as they deal with the rising number of patients.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

FDA has asked 5 US companies to voluntarily recall lots of metformin extended release after detection of NDMA contamination.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

Eli Lilly announced that the first patients have been dosed in a phase 1 study of a novel COVID-19 antibody treatment.

Roche announced the start of the REMDACTA study to evaluate tocilizumab plus remdesivir in hospitalized patients with severe COVID-19 pneumonia.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.